Effects of Immunosuppressive Drugs on Rat Renal Ischemia Reperfusion Injury

Transplantation Proceedings

Volumn 42, Issue 1, 2010, Pages 245-247

  Parra, C ^a   Salas, P ^a   Dominguez, J ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; CREATININE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFECT; HISTOLOGY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; REPERFUSION INJURY;

ANIMALS; CHOLECALCIFEROL; CREATININE; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; NEPHRECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RENAL ARTERY; REPERFUSION INJURY; SIROLIMUS;

EID: 76749152826     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.11.018     Document Type: Article

References (22)

1. Tullius S.G., and Tilney N.L. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59 (1995) 313
2. Perico N., Cattaneo D., Sayegh M.H., et al. Delayed graft function in kidney transplantation. Lancet 364 (2004) 1814
3. Boom H., Paul L.C., and de FITJER J.W. Delayed graft function in renal transplantation. Transplant Rev 18 (2004) 139
4. Pascual M., Theruvath T., Kawai T., et al. Medical progress: strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346 (2002) 580
5. Nath K.A., and Norby S.M. Reactive oxygen species and acute renal failure. Am J Med 109 (2000) 655
6. Troncoso P., Domínguez J., Martínez L., et al. Oxidative damage markers in a renal ischemia reperfusion model: the protective effect of monoaminoxidase inhibition. Transplant Proc 27 (1995) 1836
7. Kim B., Lim S., Li C., et al. Ischemia reperfusion injury activates innate immunity in rat kidneys. Transplantation 79 (2005) 1370
8. Rabb H., Daniels F., O'Donnell M., et al. Pathophysiological role of T lymphocytes in renal ischemia reperfusion injury. Am J Physiol 279 (2000) F525
9. Yokota N., Daniela F., Crosson J., et al. Protective effect of Tcell depletion in murine renal ischemia reperfusion injury. Transplantation 74 (2002) 759
10. Burne-Taney M., Ascon D., Daniela F., et al. B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol 171 (2003) 3210
11. Dong X., Swaminathan S., Bachean L., et al. Resident dendritic cells are the predominant TNF secreting cell in early renal ischemia reperfusion injury. Kidney Int 71 (2007) 619
12. Webster A.C., Lee V.W., Chapman J.R., et al. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation 81 (2006) 1234
13. Fuller T.F., Freise C.E., Serkova N., et al. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 76 (2003) 1594
14. Inman S.R., Davis N.A., Olson K.M., et al. Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury. Urology 62 (2003) 750
15. Gonçalves G.M., Cenedeze M.A., Feitoza C.Q., et al. The role of immunosuppressive drugs in aggravating renal ischemia and reperfusion injury. Transplant Proc 39 (2007) 417
16. Novitsky D., Cooper D., Rosendale J., et al. Hormonal therapy of the brain dead organ donor: experimental and clinical studies. Transplantation 82 (2006) 1396
17. Askar I., and Bozkurt M. Protective effects of immunosuppressants and steroids against ischemia- reperfusion injury in cremaster muscle flap at microcirculatory level. Microsurgery 22 (2002) 361
18. Lagaraine C., and Lebranchu Y. Effects of immunosuppressive drugs on dendritc cells and tolerante induction. Transplantation 75 suppl (2003) 37S
19. Veldman C.M., Cantorna M.T., and De Luca H.F. Expression of 1,25-dihydroxyvitamina D (3) receptor in the immune system. Arch Biochem Biophys 374 (2000) 334
20. Piemonti L., Monti P., Sironi M., et al. Vitamin D3 affects differentiation, maturation and function of human monocyte derived dendritic cells. J Immunol 164 (2000) 4443
21. Becker B., Hulett D., O'Herrin, et al. Vitamin D as inmunomodulatory therapy for kidney transplantation. Transplantation 74 (2002) 1204
22. Kim Y.O., Li C., Sun B.K., et al. Preconditioning with 1,25-dihydroxyvitamin D3 protects against subsequent ischemia-reperfusion injury in the rat kidney. Nephron Exp Nephrol 100 (2005) e85